Skip to main content

letter

. 1992 Apr 4;304(6831):913. doi: 10.1136/bmj.304.6831.913-a

The cholesterol controversy.

G D Smith, J Pekkanen

PMCID: PMC1882796 PMID: 1392768

913

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Davey Smith G., Pekkanen J. Should there be a moratorium on the use of cholesterol lowering drugs? BMJ. 1992 Feb 15;304(6824):431–434. doi: 10.1136/bmj.304.6824.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
Dorr A. E., Gundersen K., Schneider J. C., Jr, Spencer T. W., Martin W. B. Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality. J Chronic Dis. 1978 Jan;31(1):5–14. doi: 10.1016/0021-9681(78)90076-0. [DOI] [PubMed] [Google Scholar]
Muldoon M. F., Manuck S. B., Matthews K. A. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ. 1990 Aug 11;301(6747):309–314. doi: 10.1136/bmj.301.6747.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) 1981 Jun 6;282(6279):1847–1851. doi: 10.1136/bmj.282.6279.1847. [DOI] [PMC free article] [PubMed] [Google Scholar]
Wysowski D. K., Kennedy D. L., Gross T. P. Prescribed use of cholesterol-lowering drugs in the United States, 1978 through 1988. JAMA. 1990 Apr 25;263(16):2185–2188. [PubMed] [Google Scholar]

ACTIONS

RESOURCES